Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the8.33M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States8.33M100.00%